Phorbol myristic acetate enhances the production of interleukin 2.
D000818:Animals; D003208:Concanavalin A / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005260:Female; D007375:Interleukin-1; D007376:Interleukin-2 / Q000096:biosynthesis*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008211:Lymphocyte Cooperation / Q000187:drug effects; D008222:Lymphokines / Q000096:biosynthesis*; D008297:Male; D051379:Mice; D010704:Phorbols / Q000494:pharmacology*; D011506:Proteins / Q000302:isolation & purification; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D007375:Interleukin-1; D007376:Interleukin-2; D008222:Lymphokines; D010704:Phorbols; D011506:Proteins; D003208:Concanavalin A; D013755:Tetradecanoylphorbol Acetate